SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?


To: Mkilloran who wrote (18472)2/1/1999 7:38:00 PM
From: Scooter  Read Replies (1) | Respond to of 23519
 
Hey look at the bright spot.....

u can pick up VVUS at around 2 1/2 is a steal...

awesome support at 2 1/2

just think a year from now we should be at 20 1/2....

ok

still holding all my shares

Scoot



To: Mkilloran who wrote (18472)2/1/1999 7:41:00 PM
From: Mkilloran  Respond to of 23519
 
Viagra didn't take that big of a slice out of this pie....

Plenty of leftovers for MUSE....

yahoo.com.sg

That's why MUSE with a good marketing program can capture 34% of the ED market in Sweden and 37% in the UK....

Let's go Astra and Janssen ...replicate your marketing program to the other 20 countries where Muse is approved today.



To: Mkilloran who wrote (18472)2/1/1999 9:23:00 PM
From: Andreas Samson  Read Replies (1) | Respond to of 23519
 
Who EXACTLY told you that R. Walliser was hired for 'stock options, not cash....'?